<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26025091</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1559-0755</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Immunologic research</Title><ISOAbbreviation>Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.</ArticleTitle><Pagination><StartPage>306</StartPage><EndPage>315</EndPage><MedlinePgn>306-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12026-015-8661-1</ELocationID><Abstract><AbstractText>Circulating enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) is a major public health problem in the Asian-Pacific region. An EV71 vaccine for HFMD prevention is currently being developed. However, viral determinants that could influence the vaccine's efficacy have not been well characterized. In this study, we isolated and characterized several EV71 strains that are currently circulating in northern and southern China. We determined that VP1 variation is a major determinant of EV71 immunogenicity. A single amino acid variation in VP1 can lead to significant differences in the breadth and potency of immune responses against primary EV71 isolates as well as the sensitivity of EV71 to heterologous neutralizing antibody responses. We also identified EV71 strains that could induce potent immunogenic and cross-neutralizing antibody responses against diverse EV71 strains. Furthermore, these neutralizing antibodies could protect neonatal mice from lethal dose challenge with various circulating EV71 viruses. Our study provides useful information for EV71 vaccine development and evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Junliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingliang</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guanchen</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jiaxin</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xiao-Fang</ForeName><Initials>XF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunol Res</MedlineTA><NlmUniqueID>8611087</NlmUniqueID><ISSNLinking>0257-277X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26025091</ArticleId><ArticleId IdType="doi">10.1007/s12026-015-8661-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Infect Dis. 2003 Aug 15;188(4):564-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2001 Jan;22(1):200-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11158910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Nov;10(11):778-90</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2010 Nov;9(11):1097-105</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 May 9;30(22):3295-303</Citation><ArticleIdList><ArticleId IdType="pubmed">22426327</ArticleId></ArticleIdList></Reference><Reference><Citation>Vopr Virusol. 2010 Nov-Dec;55(6):4-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21381332</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2009 Oct;145(1):157-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19540282</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2012;6(8):e1737</Citation><ArticleIdList><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Jun 2;26(23):2882-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18450335</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Dermatol. 2009;54(1):26-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20049265</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Sep;47(9):2826-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19625480</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(3):e32405</Citation><ArticleIdList><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2014 May;95(Pt 5):1083-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24496826</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol Sin. 2011 Aug;26(4):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2013 Aug;9(8):1701-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2000 Jun;17(1):13-22</Citation><ArticleIdList><ArticleId IdType="pubmed">10814934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2005 Oct;3(10):765-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Infect Dis. 1999;31(4):331-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10528868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Acad Med Singapore. 2009 Feb;38(2):106-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Infect Dis J. 2006 Aug;25(8):691-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16874167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neonatol. 2014 Aug;55(4):243-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24120535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Neonatol. 2008 Aug;49(4):103-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Mar 28;26(15):1855-62</Citation><ArticleIdList><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2001 Jan 15;32(2):236-42</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 Jun 8;381(9882):2024-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2012 Oct 25;432(2):417-26</Citation><ArticleIdList><ArticleId IdType="pubmed">22819834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Dec 1;8(12):1775-83</Citation><ArticleIdList><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1974 Mar;129(3):304-9</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Jan;84(1):661-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Jul 5;367(1):91-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22762340</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2005 Aug;43(8):3835-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2012 Apr;53(4):285-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Dec 31;8(12):e83711</Citation><ArticleIdList><ArticleId IdType="pubmed">24391812</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2010 Sep;14(9):e775-80</Citation><ArticleIdList><ArticleId IdType="pubmed">20599410</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2002 May 1;34 Suppl 2:S52-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Oct 28;28(46):7444-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20831911</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2001 Dec 12;20(5-6):895-904</Citation><ArticleIdList><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Health Threats J. 2013 Sep 10;6:19780</Citation><ArticleIdList><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2000 Sep;31(3):678-83</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2007 Sep;9(11):1299-306</Citation><ArticleIdList><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>